| Jan'20 | Jan'19 | Jan'18 | Jan'17 | Jan'16 | Jan'15 | Jan'14 | Jan'13 | Jan'12 | Jan'11 |
|---|---|---|---|---|---|---|---|---|---|
Operating activities | |||||||||
Net income/(loss) | |||||||||
3,576 | -550 | -9,976 | -12,474 | -4,409 | -181 | 21,027 | -18,485 | -4,959 | 4,375 |
Adjustments to reconcile net income/(loss) to net cash flows provided by operating activities | |||||||||
Depreciation and amortization | |||||||||
4,437 | 4,575 | 5,031 | 5,521 | 5,929 | 5,897 | 5,785 | 5,806 | 5,582 | 6,070 |
Gain on disposal of subsidiary | |||||||||
- | - | 166 | 127 | 8,099 | 188 | 11,449 | 0 | - | - |
Impairment expense on discontinued operations | |||||||||
- | - | - | - | 6,480 | 0 | - | 1,520 | 0 | - |
Deferred tax (benefit)/expense | |||||||||
-211 | 211 | -958 | -33 | -249 | 1,231 | -3,190 | 12,594 | -989 | -3,752 |
Stock-based compensation expense | |||||||||
1,011 | 1,165 | 1,447 | 1,446 | 278 | 124 | 196 | 484 | 621 | 895 |
Provision on uncollectible accounts | |||||||||
101 | 71 | 15 | 657 | - | - | - | - | - | - |
Loss on consolidation of joint venture | |||||||||
- | - | - | 1,620 | 0 | - | - | - | - | - |
Income from joint venture | |||||||||
- | - | - | - | -602 | -1,960 | -528 | -1,386 | - | - |
Loss from joint venture | |||||||||
- | - | - | - | - | - | - | - | -1,558 | -983 |
Cash surrender value on life insurance policies | |||||||||
- | - | - | 135 | -206 | 145 | 164 | 163 | -86 | 377 |
Loss on disposal of fixed assets | |||||||||
-318 | -46 | -219 | - | - | - | - | - | - | -69 |
Gain on sale of marketable securities | |||||||||
- | - | 142 | 0 | - | - | - | - | - | - |
Changes in operating assets and liabilities | |||||||||
Change in contract assets and contract liabilities | |||||||||
- | - | - | 296 | -1,268 | -765 | 1,110 | 34 | 62 | - |
Provision on uncollectible accounts | |||||||||
- | - | - | - | -59 | -80 | -158 | 114 | - | - |
(Gain) loss on disposal of fixed assets | |||||||||
- | - | - | 292 | -101 | 17 | -328 | -64 | -115 | - |
Accounts payable | |||||||||
-2,609 | -3,576 | 4,551 | -1,917 | 5,819 | -4,612 | -4,438 | 2,908 | 1,308 | 4,820 |
Accrued compensation and payroll taxes | |||||||||
-576 | 1,226 | -1,780 | -9,227 | 299 | -3,055 | 6,026 | -844 | -1,852 | -2,583 |
Inventories | |||||||||
2,225 | -4,360 | 3,274 | -5,452 | -4,027 | -3,250 | -8,608 | 2,080 | 4,683 | -1,706 |
Customers' deposits | |||||||||
-1,507 | -1,517 | 2,596 | - | - | - | - | - | - | - |
Customers' deposits | |||||||||
- | - | - | -2,303 | -2,400 | -28 | -198 | 5,138 | 520 | -1,607 |
Income taxes receivable and payable | |||||||||
-668 | 35 | -75 | -128 | 620 | -687 | 2,564 | -384 | 8 | 1,214 |
Prepaid expenses and other current assets | |||||||||
-1,749 | 700 | 471 | 997 | -1,914 | -1,000 | 619 | -563 | 234 | 1,408 |
Accounts receivable | |||||||||
-1,749 | 354 | 1,076 | -13,698 | 2,809 | -3,314 | 18,015 | -204 | -8,075 | 488 |
Costs and estimated earnings in excess of billings on uncompleted contracts | |||||||||
-910 | -547 | 1,455 | - | - | - | - | - | - | - |
Notes receivable | |||||||||
- | - | - | - | - | -849 | -331 | 0 | - | - |
Other assets and liabilities | |||||||||
143 | -529 | -762 | 6,514 | 8,675 | 449 | 816 | 740 | 2,292 | -763 |
Net cash provided by operating activities | |||||||||
4,090 | 4,978 | -1,842 | -5,457 | -2,897 | 3,498 | 6,400 | 5,347 | -190 | 8,714 |
Investing activities | |||||||||
Acquisition of interest in subsidiary, net of cash acquired | |||||||||
- | - | - | 4,672 | 0 | - | - | - | - | - |
Net proceeds from sale of discontinued operations | |||||||||
- | - | - | -9,606 | -16,373 | -109 | -15,172 | 0 | - | - |
Capital expenditures | |||||||||
1,902 | 1,361 | 2,532 | 2,257 | 6,457 | 5,878 | 2,761 | 5,360 | 10,086 | - |
Proceeds from surrender of corporate-owned life insurance policies | |||||||||
- | - | - | -3,185 | 0 | 0 | - | - | - | - |
Proceeds from sale of marketable securities | |||||||||
- | - | 142 | 0 | - | - | - | - | - | - |
Receipts on loan from joint venture | |||||||||
- | - | - | - | - | 0 | - | - | - | - |
Receipts on loan from joint venture | |||||||||
- | - | - | - | -1,890 | - | - | 989 | 0 | - |
Additions to property, plant and equipment | |||||||||
- | - | - | - | - | - | - | - | - | -4,030 |
Proceeds from sales of property and equipment | |||||||||
- | - | 1 | 4,356 | 2,059 | 24 | 16 | 95 | 18 | 96 |
Net cash used in investing activities | |||||||||
-1,902 | -1,361 | -2,389 | 10,218 | 13,865 | -5,745 | 12,427 | -6,254 | -10,068 | -3,934 |
Financing activities | |||||||||
Proceeds from revolving lines | |||||||||
73,225 | 64,736 | 40,485 | 40,033 | 105,636 | 85,270 | 102,344 | - | - | - |
Proceeds from debt | |||||||||
- | - | - | 6,059 | 918 | 661 | 5,197 | 194,035 | 195,363 | 151,258 |
Proceeds from borrowing against life insurance policies | |||||||||
- | - | - | - | 1,916 | 0 | - | - | - | - |
Payments of debt on revolving lines | |||||||||
72,973 | 62,759 | 37,354 | 49,303 | 105,378 | 83,150 | 109,501 | 185,659 | - | - |
Debt issuance costs | |||||||||
- | 946 | - | - | - | - | - | - | - | - |
Payments of other debt | |||||||||
358 | 350 | 211 | - | - | - | - | - | - | - |
Payments of other debt | |||||||||
- | - | - | 10,151 | 2,544 | 3,641 | 7,643 | 4,025 | 196,671 | 148,904 |
Payments of borrowing against life insurance policies | |||||||||
- | - | - | - | 1,916 | - | - | - | - | - |
Increase (decrease) in drafts payable | |||||||||
-129 | 192 | 34 | -323 | -467 | 629 | -3,125 | -8 | -475 | 1,166 |
Payments on finance lease obligations | |||||||||
287 | 250 | - | - | - | - | - | - | - | - |
Proceeds (payments) on capitalized lease obligations | |||||||||
- | - | 546 | - | - | - | - | - | - | - |
Release of treasury stock | |||||||||
- | - | 170 | - | - | - | - | - | - | - |
Stock options exercised and taxes paid related to restricted shares vested | |||||||||
221 | 511 | -214 | - | - | - | - | - | - | - |
Payments (borrowings) on capitalized lease obligations | |||||||||
- | - | - | - | 998 | 704 | 603 | 591 | 293 | 198 |
Proceeds (payments) on capitalized lease obligations | |||||||||
- | - | - | -1,677 | - | - | - | - | - | - |
Release of treasury stock | |||||||||
- | - | - | 120 | -290 | 0 | - | - | - | - |
Stock options exercised | |||||||||
- | - | - | 297 | 98 | 389 | 1,592 | 35 | 210 | 45 |
Tax benefit of stock options exercised | |||||||||
- | - | - | - | - | - | - | 11 | - | - |
Tax benefit of stock options exercised | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Tax benefit of stock options exercised | |||||||||
- | - | - | - | - | - | - | - | - | 2 |
Net cash (used in)/provided by financing activities | |||||||||
-301 | 1,134 | 3,456 | -14,945 | -3,025 | -546 | -11,739 | 3,798 | -1,866 | 3,369 |
Effect of Exchange Rate on Cash and Cash Equivalents | |||||||||
- | - | - | - | -1,212 | -702 | -727 | -66 | -385 | 502 |
Net (decrease) increase in cash and cash equivalents | |||||||||
- | - | - | - | 6,731 | -3,495 | 6,361 | 2,825 | -12,509 | 8,651 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||||||
34 | -335 | 395 | -70 | - | - | - | - | - | - |
Net increase in cash, cash equivalents and restricted cash | |||||||||
1,921 | 4,416 | -380 | -10,254 | - | - | - | - | - | - |
Supplemental cash flow information | |||||||||
Interest paid | |||||||||
902 | 1,298 | 804 | - | - | - | - | - | - | - |
Interest paid | |||||||||
- | - | - | 773 | 749 | 1,288 | 1,958 | 2,314 | 2,117 | - |
Income taxes paid | |||||||||
2,107 | 1,731 | 1,080 | 1,381 | 970 | 2,988 | 409 | 200 | 439 | - |
Fixed assets acquired under finance leases - non-cash | |||||||||
848 | - | 841 | - | - | - | - | - | - | - |
Fixed assets acquired under capital leases | |||||||||
- | - | - | 8 | 0 | 680 | 107 | 569 | - | - |
Funds held in escrow related to the sale of Filtration assets | |||||||||
- | - | - | 502 | 1,905 | 0 | 1,125 | 0 | - | - |
Interest expense | |||||||||
- | - | - | - | - | - | - | - | - | 1,992 |
Income taxes paid, net of refunds | |||||||||
- | - | - | - | - | - | - | - | - | 1,108 |